Are people considering psychedelics in the next year?
Core finding
In a Verasight survey of 1,000 U.S. adults conducted May 1 to 4, 2026, 74% of Americans said they are not considering taking a psychedelic in the upcoming year.
Another 11% said they are curious but not sure, 8% did not know or had not thought about it, and 7% said yes.
Topline distribution
74% are not considering psychedelics in the upcoming year.
Are you considering taking a psychedelic in the upcoming year? Psychedelics are compounds like psilocybin (magic mushrooms), MDMA (molly, ecstasy), LSD (acid), but do NOT include cannabis.
n = 1,000 · May 1–4, 2026 · MoE ±3.3%
Methodology
Full methodology →| Mode | Verasight panel recruited via random address-based sampling, random person-to-person text messaging, and dynamic online targeting |
|---|---|
| Population | US adults age 18+ |
| Field dates | May 1–4, 2026 |
| Base (unweighted) | 1,000 |
| Margin of error | ±3.3% |
| Module | 2 |
| Sponsor | Verasight |
| Weight variable | weight |
| Weighting targets | age, race/ethnicity, sex, income, education, region, metropolitan status |
Sources
- reports.verasight.io/r/sbm-2026
Are you considering taking a psychedelic in the upcoming year? Psychedelics are compounds like psilocybin (magic mushrooms), MDMA (molly, ecstasy), LSD (acid), but do NOT include cannabis.
Cite this question
SBM Omnibus Survey #2026-049, fielded May 1-4, 2026, N=1,000 US adults age 18+, +/- 3.3%.